Cynaptec is a biopharmaceutical company focused on creating novel treatments for neurological and psychiatric conditions.
Cynaptec Pharmaceuticals has raised $6.0M in total funding. The most recent round was Corporate Round. The last funding was announced in June 2025.
Cynaptec Pharmaceuticals's investors include Lobe Sciences.
Cynaptec Pharmaceuticals is headquartered in Vancouver, Canada.
Cynaptec is a biopharmaceutical company focused on creating novel treatments for neurological and psychiatric conditions.
Cynaptec Pharmaceuticals is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cynaptec Pharmaceuticals — Funding & Investors." VCBacked, June 18, 2025, https://www.vcbacked.co/company/cynaptec-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2025). Cynaptec Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cynaptec-pharmaceuticals
{{cite web |title=Cynaptec Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/cynaptec-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated